BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 14584523)

  • 1. Emerging trends in oral delivery of peptide and protein drugs.
    Mahato RI; Narang AS; Thoma L; Miller DD
    Crit Rev Ther Drug Carrier Syst; 2003; 20(2-3):153-214. PubMed ID: 14584523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules.
    Choonara BF; Choonara YE; Kumar P; Bijukumar D; du Toit LC; Pillay V
    Biotechnol Adv; 2014 Nov; 32(7):1269-1282. PubMed ID: 25099657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The colon as a possible target for orally administered peptide and protein drugs.
    Haupt S; Rubinstein A
    Crit Rev Ther Drug Carrier Syst; 2002; 19(6):499-551. PubMed ID: 12822734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral peptide and protein delivery: intestinal obstacles and commercial prospects.
    Smart AL; Gaisford S; Basit AW
    Expert Opin Drug Deliv; 2014 Aug; 11(8):1323-35. PubMed ID: 24816134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approaches to improve intestinal and transmucosal absorption of peptide and protein drugs.
    Yamamoto A; Ukai H; Morishita M; Katsumi H
    Pharmacol Ther; 2020 Jul; 211():107537. PubMed ID: 32201316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral peptide delivery: Translational challenges due to physiological effects.
    Tyagi P; Pechenov S; Anand Subramony J
    J Control Release; 2018 Oct; 287():167-176. PubMed ID: 30145135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein drug oral delivery: the recent progress.
    Lee HJ
    Arch Pharm Res; 2002 Oct; 25(5):572-84. PubMed ID: 12433186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of particulate drug delivery systems for oral delivery of Peptide and protein drugs.
    Christophersen PC; Fano M; Saaby L; Yang M; Nielsen HM; Mu H
    Curr Pharm Des; 2015; 21(19):2611-28. PubMed ID: 25876916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies and industrial perspectives to improve oral absorption of biological macromolecules.
    Liu C; Kou Y; Zhang X; Cheng H; Chen X; Mao S
    Expert Opin Drug Deliv; 2018 Mar; 15(3):223-233. PubMed ID: 29111841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Improvement of transmucosal absorption of biologically active peptide drugs].
    Yamamoto A
    Yakugaku Zasshi; 2001 Dec; 121(12):929-48. PubMed ID: 11766407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional Delivery Systems for Advanced oral Uptake of Peptide/Protein Drugs.
    Park JW; Kim SJ; Kwag DS; Kim S; Park J; Youn YS; Bae YH; Lee ES
    Curr Pharm Des; 2015; 21(22):3097-110. PubMed ID: 26027575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral delivery of peptide drugs: barriers and developments.
    Hamman JH; Enslin GM; Kotzé AF
    BioDrugs; 2005; 19(3):165-77. PubMed ID: 15984901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approaches for enhancing oral bioavailability of peptides and proteins.
    Renukuntla J; Vadlapudi AD; Patel A; Boddu SH; Mitra AK
    Int J Pharm; 2013 Apr; 447(1-2):75-93. PubMed ID: 23428883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery.
    Yun Y; Cho YW; Park K
    Adv Drug Deliv Rev; 2013 Jun; 65(6):822-32. PubMed ID: 23123292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Improvement of Intestinal and Transmucosal Absorption of Peptide and Protein Drugs].
    Yamamoto A
    Yakugaku Zasshi; 2024; 144(7):697-714. PubMed ID: 38945845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral colon-specific drug delivery of protein and peptide drugs.
    Sinha V; Singh A; Kumar RV; Singh S; Kumria R; Bhinge J
    Crit Rev Ther Drug Carrier Syst; 2007; 24(1):63-92. PubMed ID: 17430100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opportunities and challenges for oral delivery of hydrophobic versus hydrophilic peptide and protein-like drugs using lipid-based technologies.
    Griffin BT; O'Driscoll CM
    Ther Deliv; 2011 Dec; 2(12):1633-53. PubMed ID: 22833986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of gastrointestinal tract for amended delivery of protein/peptide therapeutics: strategies and industrial perspectives.
    Pawar VK; Meher JG; Singh Y; Chaurasia M; Surendar Reddy B; Chourasia MK
    J Control Release; 2014 Dec; 196():168-83. PubMed ID: 25305562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some approaches to improve bioavailability of peptides and proteins through oral and other mucosal routes.
    Vyas SP; Venugopalan P; Sood A; Mysore N
    Pharmazie; 1997 May; 52(5):339-45. PubMed ID: 9183784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifunctional matrices for oral peptide delivery.
    Bernkop-Schnürch A; Walker G
    Crit Rev Ther Drug Carrier Syst; 2001; 18(5):459-501. PubMed ID: 11763498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.